Press "Enter" to skip to content

White House drops Heidi Overton’s FDA nomination

Key takeaways:

  • The White House dropped Dr. Heidi Overton’s nomination for FDA commissioner before a scheduled Senate committee vote.
  • Republican Sen. Bill Cassidy said he remained undecided about her nomination ahead of the vote, The Guardian reported.
  • Overton called for stricter regulation of mifepristone in a 2023 policy brief; Reproductive Freedom for All welcomed the withdrawal.

The White House has dropped Dr. Heidi Overton’s nomination to lead the Food and Drug Administration, ending her bid for the post before a scheduled Senate committee vote, according to a senior administration official and other people familiar with the decision who spoke to CBS News.

President Donald Trump nominated Overton, a physician and prominent opponent of abortion, in August. The Senate health, labor and pensions committee had been scheduled to vote on her nomination Wednesday. Republican Sen. Bill Cassidy said ahead of the vote that he remained undecided, The Guardian reported.

The FDA regulates medication abortion, an issue on which Overton had taken a public position. In a 2023 policy brief for the conservative America First Policy Institute, she said Congress should strictly regulate the abortion pill mifepristone “to protect women and children.” She also criticized federal policies that allow abortion pills to be mailed and wrote that abortion “is corrosive to children, women, and society broadly,” according to The Guardian.

Reproductive Freedom for All, a reproductive rights group formerly known as NARAL Pro-Choice America, welcomed the decision. Its president and CEO, Mini Timmaraju, said Overton “posed a serious threat to the future of medication abortion access.”

“Voters rejected that anti-abortion agenda nationwide, and our members kept the pressure on to tank her confirmation,” Timmaraju said. “If Republicans try to rush through another nominee who threatens our healthcare, we’re ready to keep fighting.”

CBS News reported that Axios was first to report the White House’s decision. The accounts did not identify a replacement nominee or state why the nomination was dropped.

Sources

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Share via
Copy link
Powered by Social Snap